1 / 29

Commissioning Patient Centered Care & Improving Outcomes for People with Cancer

Commissioning Patient Centered Care & Improving Outcomes for People with Cancer. Di Riley Associate Director, Clinical Outcomes NCIN. To cover:. Improving Outcomes Long Term Conditions in Cancer Commissioning Patient Centred Services. What are Outcomes. Clinical v Patient

felcia
Download Presentation

Commissioning Patient Centered Care & Improving Outcomes for People with Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Commissioning Patient Centered Care & Improving Outcomes for People with Cancer Di Riley Associate Director, Clinical Outcomes NCIN

  2. To cover: Improving Outcomes Long Term Conditions in Cancer Commissioning Patient Centred Services

  3. What are Outcomes Clinical v Patient Survival Quality of Life Stage of disease Return to normality Co-morbidity Treatment Toxicity & side effects Role of National Cancer Intelligence Network?

  4. NCIN Goal Goal for NCIN: To develop the best cancer information service of any large country in the world Why? To provide feedback on performance to clinical teams To promote stronger commissioning To provide informed choice for patients To provide a unique opportunity for health services research i.e. To improve outcomes

  5. NCIS Example: Trends in one year cancer survival, breast cancer, females, England, 1985-2004 (five-year moving average) NCIN Publications Cancer Incidence by Ethnicity **June 2009** Cancer Incidence by Deprivation, England, 95-2004**NEW** Cancer Prevalence (undertaken by Thames Cancer Registry) Cancer Incidence and Mortality by Cancer Network, UK, 2005 1 Year Survival Trends (incl. 1 year Survival by Cancer Network), Eng, 1985-2004

  6. Improving Outcomes • Public awareness • Stage at diagnosis • Co-morbidities • at & after diagnosis • Children and Young Peole • ‘Outcomes Measures’ • clinical • patient reported • International Benchmarking

  7. Long Term Conditions: ....... A condition that cannot at present be cured, but can be controlled by medication and other therapies e.g. Diabetes Heart Disease Chronic obstructive pulmonary disease Over 15.4 million people in England with a LTC (~30%)

  8. UK Population Between 1983 & 2008 % >65 and over, inc. from 15% to16%, an increase of 1.5 m people. By 2033, 23% of population will be >65 years of age By 2033, only 18% will be <16 years Population by age, UK, 1983, 2008 and 2033, ONS In 2008, median ages Women 40 years Men 38 years

  9. Population aged 65+ years

  10. Cancer Incidence Since 1977, incidence rate for cancer has increased in Great Britain, by 25% 14% increase in men 32% increase in women

  11. Lung Cancer Incidence

  12. Prostate Cancer Survival 5 year relative survival rates Increased by an average of 12% every 5 years between 1986 & 1999 42% to 65%

  13. Breast Cancer Survival For women diagnosed with breast cancer in 2001-2006 (England) 5-year relative survival rates - 82% compared with only 52% thirty years earlier in 1971-75 CR-UK

  14. Incidence and Mortality

  15. UK Cancer Prevalence

  16. So.....the implications! • Ageing population • Increasing presence of long term conditions • Increasing risk of cancer • Increasing cancer incidence • Increased survival • Reductions in mortality • More living with cancer So, more people with LTC will also have cancer What about treatment effects?

  17. Treatment Effects

  18. Commissioning considerations Long term conditions (Ageing population) Inc. cancer incidence Increasing survival Increasing prevalence Late effects Long term effects/conditions What drives Commissioning – cancer or condition?

  19. Patient Centred Commissioning Strong cancer commissioning is vital to ensure: • high quality services are delivered • reflect needs of local populations • reflect national priorities • cost effective

  20. Commissioning is Complex? • Many types of cancer • Many different care pathways • Clinical teams in the community, DGHs and specialist centres. • Some aspects require highly specialised commissioning at a national or SHA level. • Other aspects overlap with non-cancer services (diagnostics & ?LTC) and commissioned at a more local level.

  21. An example? • A known cancer patient visits GP with breathlessness • Refer back to oncology team? • Refer to a cardiologist? • Refer to a respiratory physician? • Commissioners view: • Commission patient pathways • Underlying cause identified and treated • Establish a ‘MDT breathlessness clinic’ • Cancer MDT involved

  22. The Cancer Commissioning Toolkit (CCT)

  23. Programme Budgeting

  24. Cancer Commissioning Guidance was launched in January 2009 as a ‘sister’ product to the CCT • Sets out the key issues and questions for commissioners for: • Assessing health needs • Reviewing services • Monitoring performance • Service specifications • Easy to use format • Interactive • Quick links

  25. Each section of the Cancer Commissioning Guidance contains Key Questions for commissioners – and where to find the answers

  26. Patient Centred Care Late Effects Long Term Conditions Long Term Effects Holistic Needs Pat. Reported Outcomes Rehabilitation Services Survivorship

  27. Commissioning considerations Long term conditions (Ageing population) Inc. cancer incidence Increasing survival Increasing prevalence Late effects Long term effects/conditions What drives Commissioning – Patient Pathways?

  28. Any Questions? www.ncin.org.uk

More Related